Enanta Pharmaceuticals | ENTA - Market Capitalization


Enanta Pharmaceuticals reported $278.6M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 10.84B 664M Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Halozyme Therapeutics USD 10.91B 1.63B Aug/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Incyte USD 26.84B 4.19B Aug/2026
Insmed USD 19.68B 3.43B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Ligand Pharmaceuticals USD 5.31B 1.02B Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.17B 14.73B Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026